Patients are relying on Lyft, Uber to travel far distances to medical care

Ake­bia now ex­pects to re­file its chron­ic kid­ney dis­ease treat­ment vadadu­s­tat by the end of Sep­tem­ber. The biotech said Thurs­day morn­ing that it had a

A real-world analysis presented at the American Society of Hematology annual meeting showed that the refusal rate for autologous hematopoietic stem cell transplantation among patients